Inventory, Net in USD of Intra-Cellular Therapies, Inc. from Q1 2020 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Summary
Intra-Cellular Therapies, Inc. quarterly Inventory, Net history and change rate from Q1 2020 to Q4 2024.
  • Intra-Cellular Therapies, Inc. Inventory, Net for the quarter ending 31 Dec 2024 was $26.3M, a 126% increase year-over-year.
Inventory, Net, Quarterly (USD)
Inventory, Net, YoY Quarterly Change (%)

Intra-Cellular Therapies, Inc. Quarterly Inventory, Net (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $26.3M +$14.6M +126% 31 Dec 2024 10-K 21 Feb 2025
Q3 2024 $23.5M -$19.4M -45.2% 30 Sep 2024 10-Q 30 Oct 2024
Q2 2024 $20.1M -$21.8M -52.1% 30 Jun 2024 10-Q 07 Aug 2024
Q1 2024 $15.9M -$12.4M -43.7% 31 Mar 2024 10-Q 07 May 2024
Q4 2023 $11.6M -$12.3M -51.3% 31 Dec 2023 10-K 21 Feb 2025
Q3 2023 $43M +$19.4M +82.2% 30 Sep 2023 10-Q 02 Nov 2023
Q2 2023 $41.9M +$16.9M +67.4% 30 Jun 2023 10-Q 03 Aug 2023
Q1 2023 $28.3M +$20.4M +259% 31 Mar 2023 10-Q 04 May 2023
Q4 2022 $23.9M +$16M +201% 31 Dec 2022 10-K 22 Feb 2024
Q3 2022 $23.6M +$15.4M +189% 30 Sep 2022 10-Q 03 Nov 2022
Q2 2022 $25M +$17.3M +222% 30 Jun 2022 10-Q 09 Aug 2022
Q1 2022 $7.89M +$314K +4.14% 31 Mar 2022 10-Q 10 May 2022
Q4 2021 $7.95M +$892K +12.6% 31 Dec 2021 10-K 01 Mar 2023
Q3 2021 $8.17M +$5.22M +177% 30 Sep 2021 10-Q 09 Nov 2021
Q2 2021 $7.77M +$5.43M +233% 30 Jun 2021 10-Q 09 Aug 2021
Q1 2021 $7.58M +$6.19M +445% 31 Mar 2021 10-Q 10 May 2021
Q4 2020 $7.06M 31 Dec 2020 10-K 01 Mar 2022
Q3 2020 $2.95M 30 Sep 2020 10-Q 09 Nov 2020
Q2 2020 $2.34M 30 Jun 2020 10-Q 10 Aug 2020
Q1 2020 $1.39M 31 Mar 2020 10-Q 07 May 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.